|
Gao, Weimin; Romkes, Marjorie; Zhong, Shilong et al. (2010) Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol Rep 24:257-62
|
|
Cecchetti, Alfred A; Parmanto, Bambang; Vecchio, Marcella L et al. (2009) Team building: electronic management-clinical translational research (eM-CTR) systems. Clin Transl Sci 2:449-55
|
|
Backer, Lorraine C; Lan, Qing; Blount, Benjamin C et al. (2008) Exogenous and endogenous determinants of blood trihalomethane levels after showering. Environ Health Perspect 116:57-63
|
|
Zgheib, N K; Frye, R F; Tracy, T S et al. (2007) Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity. Br J Clin Pharmacol 63:477-87
|
|
Zgheib, Nathalie K; Frye, Reginald F; Tracy, Timothy S et al. (2006) Validation of incorporating flurbiprofen into the Pittsburgh cocktail. Clin Pharmacol Ther 80:257-63
|
|
Bebia, Zourab; Buch, Shama C; Wilson, John W et al. (2004) Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin Pharmacol Ther 76:618-27
|
|
Carcillo, Joseph A; Adedoyin, Adedayo; Burckart, Gilbert J et al. (2003) Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation. Clin Pharmacol Ther 73:456-67
|
|
Nolin, Thomas D; Frye, Reginald F (2003) Stereoselective determination of the CYP2C19 probe drug mephenytoin in human urine by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 783:265-71
|
|
Branch, R A; Adedoyin, A; Frye, R F et al. (2000) In vivo modulation of CYP enzymes by quinidine and rifampin. Clin Pharmacol Ther 68:401-11
|
|
Adedoyin, A; Stiff, D D; Smith, D C et al. (1998) All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes. Cancer Chemother Pharmacol 41:133-9
|
Showing the most recent 10 out of 17 publications
